Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 302

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival

Open access
Paulson, Kelly G., Iyer, Jayasri G., Tegeder, Andrew R., Thibodeau, Renee, Schelter, Janell, Koba, Shinichi, Schrama, David, Simonson, William T., Lemos, Bianca D., Byrd, David R., Koelle, David M., Galloway, Denise A., Leonard, J. Helen, Madeleine, Margaret M., Argenyi, Zsolt B., Disis, Mary L., Becker, Juergen C., Cleary, Michele A., Nghiem, Paul·2011·Journal of Clinical Oncology

Abstract

Purpose: Merkel cell carcinoma (MCC) is a polyomavirus-associated skin cancer that is frequently lethal and lacks established prognostic biomarkers. This study sought to identify biomarkers that improve prognostic accuracy and provide insight into MCC biology. Patients and Methods: Gene expression profiles of 35 MCC tumors were clustered based on prognosis. The cluster of genes overexpressed in good-prognosis tumors was tested for biologic process enrichment. Relevant mRNA expression differences were confirmed by quantitative polymerase chain reaction and immunohistochemistry. An independent set of 146 nonoverlapping MCC tumors (median follow-up, 25 months among 116 living patients) was employed for biomarker validation. Univariate and multivariate Cox regression analyses were performed. Results: Immune response gene signatures were prominent in patients with good prognoses. In particular, genes associated with cytotoxic CD8+ lymphocytes were overexpressed in tumors from patients with favorable prognoses. In the independent validation set, cases with robust intratumoral CD8+ lymphocyte infiltration had improved outcomes (100% MCC-specific survival, n = 26) compared with instances characterized by sparse infiltration (60% survival, n = 120). Only stage and intratumoral CD8 infiltration (but not age, sex, or CD8+ lymphocytes localized to the tumor-stroma interface) were significant in both univariate and multivariate Cox regression analyses. Notably, traditional histologic identification of tumor-infiltrating lymphocytes was not a significant independent predictor of survival. Conclusion: Intratumoral CD8+ lymphocyte infiltration can be readily assessed on paraffin-embedded tissue, is independently associated with improved MCC-specific survival, and therefore, may provide prognostic information that enhances established MCC staging protocols.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1200/jco.2010.30.6308

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 302

Metadata

Authors
Paulson, K. G., Iyer, J. G., Tegeder, A. R., Thibodeau, R., Schelter, J., Koba, S., Schrama, D., Simonson, W. T., Lemos, B. D., Byrd, D. R., Koelle, D. M., Galloway, D. A., Leonard, J. H., Madeleine, M. M., Argenyi, Z. B., Disis, M. L., Becker, J. C., Cleary, M. A., & Nghiem, P.
Venue
Journal of Clinical Oncology
Published
2011-04-20
Volume
29
Issue
12
Pages
1539-1546
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W2139541665
Cited by
302
References
3
FWCI
12.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival. https://app.cochat.ai/papers/10.1200/jco.2010.30.6308
The paper
Paulson, K. G., Iyer, J. G., Tegeder, A. R., Thibodeau, R., Schelter, J., Koba, S., Schrama, D., Simonson, W. T., Lemos, B. D., Byrd, D. R., Koelle, D. M., Galloway, D. A., Leonard, J. H., Madeleine, M. M., Argenyi, Z. B., Disis, M. L., Becker, J. C., Cleary, M. A., & Nghiem, P. (2011). Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2010.30.6308

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.